Vincent Perrone | Director-Corporate Communication |
Steven Shallcross | Chief Executive and Financial Officer |
Michael Kaleko | Senior Vice President-Research and Development |
Vince Wacher | Head-Product and Corporate Development |
Michael Okunewitch | Maxim Group |
Jim Molloy | Alliance Global Partners |
Good afternoon, and welcome to Synthetic Biologics 2021 First Quarter Investor Conference Call. [Operator Instructions] Please note, today’s event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director of Corporate Communication at Synthetic Biologics. Vincent, please go ahead.
Thank you, Rocco, and good afternoon, everyone.